Fresenius Kabi Compounding Recalls Vancomycin HCl Injection Due to Sterility Concerns
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Fresenius Kabi Compounding, LLC has issued a voluntary nationwide recall for 1,578 bags of Vancomycin HCl injection over concerns regarding a lack of assurance of sterility.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Drugs.
What Happened
Fresenius Kabi Compounding, LLC, operating as Fagron Sterile Services in Canton, MA, has initiated a voluntary recall of Vancomycin HCl injection products. The recall was triggered due to a lack of assurance of sterility, which poses a potential risk to patient safety. The FDA classified this as a Class II recall on February 13, 2026, following the firm's initial notification on February 5, 2026.
Which Products Are Affected
The recall affects 1,578 bags of the following medication distributed nationwide across the United States:
- Product Name: vancomycin HCl, 1.5 grams, 1.5 grams added to 500 mL, 0.9% Sodium Chloride Injection, USP
- NDC: 71506-016-59
- Lot Number: C274-000049628
- Expiration Date: 3-May-26
- Manufacturer/Labeler: Fagron Sterile Services / Fresenius Kabi Compounding, LLC
What You Should Do
Healthcare providers and facilities should immediately examine their stock to identify and quarantine the affected lot. Fresenius Kabi Compounding, LLC has initiated notification to customers via letter. For further information regarding the return process or clinical concerns, stakeholders can contact the firm at their facility located at 20 Dan Rd, Canton, MA 02021.
Why This Matters
Injectable medications that lack assurance of sterility present a significant health hazard, as they can introduce contaminants directly into a patient's bloodstream, potentially leading to serious infections or life-threatening complications.
Source
This report is based on official recall data provided by the FDA under Recall Number D-0336-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.